AU3337297A - Fragments of leptin (ob protein) - Google Patents
Fragments of leptin (ob protein)Info
- Publication number
- AU3337297A AU3337297A AU33372/97A AU3337297A AU3337297A AU 3337297 A AU3337297 A AU 3337297A AU 33372/97 A AU33372/97 A AU 33372/97A AU 3337297 A AU3337297 A AU 3337297A AU 3337297 A AU3337297 A AU 3337297A
- Authority
- AU
- Australia
- Prior art keywords
- leptin
- fragments
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Child & Adolescent Psychology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9611775 | 1996-06-06 | ||
GBGB9611775.9A GB9611775D0 (en) | 1996-06-06 | 1996-06-06 | Novel compounds |
GB9618540 | 1996-09-05 | ||
GBGB9618540.0A GB9618540D0 (en) | 1996-09-05 | 1996-09-05 | Novel compounds |
GB9703493 | 1997-02-20 | ||
GBGB9703493.8A GB9703493D0 (en) | 1997-02-20 | 1997-02-20 | Novel compounds |
PCT/EP1997/002968 WO1997046585A2 (en) | 1996-06-06 | 1997-06-04 | Fragments of leptin (ob protein) |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU71962/00A Division AU7196200A (en) | 1996-06-06 | 2000-12-01 | Fragments of leptin (ob protein) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3337297A true AU3337297A (en) | 1998-01-05 |
Family
ID=27268305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU33372/97A Abandoned AU3337297A (en) | 1996-06-06 | 1997-06-04 | Fragments of leptin (ob protein) |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0912609A2 (es) |
JP (1) | JP2000512137A (es) |
KR (1) | KR20000016402A (es) |
CN (1) | CN1221426A (es) |
AR (1) | AR008765A1 (es) |
AU (1) | AU3337297A (es) |
BR (1) | BR9709529A (es) |
CA (1) | CA2257240A1 (es) |
CZ (1) | CZ397898A3 (es) |
IL (1) | IL127153A0 (es) |
NO (1) | NO985683L (es) |
NZ (1) | NZ332879A (es) |
PL (1) | PL330361A1 (es) |
TR (1) | TR199802534T2 (es) |
WO (1) | WO1997046585A2 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2335107C (en) | 1998-07-28 | 2010-01-19 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Leptin-mediated gene-induction |
US7208572B2 (en) | 1998-08-21 | 2007-04-24 | Albany Medical College | Leptin-related peptides |
US6777388B1 (en) | 1998-08-21 | 2004-08-17 | Clf Medical Technology Acceleration Program, Inc. | Leptin-related peptides |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
CA2388417A1 (en) | 1999-09-22 | 2001-03-29 | Genset | Methods of screening for compounds that modulate the lsr-leptin interaction and their use in the prevention and treatment of obesity-related diseases |
AU8178401A (en) | 2000-05-22 | 2001-12-03 | Vlaams Interuniv Inst Biotech | Receptor-based interaction trap |
ATE475094T1 (de) | 2001-10-22 | 2010-08-15 | Amgen Inc | Verwendung von leptin zur behandlung von lipoatrophie im menschen und verfahren zur bestimmmung einer prädisposition gegenüber der behandlung |
DE602004012759T2 (de) | 2003-09-08 | 2008-07-17 | Laboratoires Serono S.A., Coinsins | Behandlung von fibrosen |
CN1961000B (zh) | 2004-02-11 | 2011-05-04 | 安米林药品公司 | 具有可选择特性的杂合多肽 |
EP1812038A1 (en) | 2004-11-18 | 2007-08-01 | VIB vzw | Fibronectin iii domain as leptin receptor antagonists |
MX2007009760A (es) | 2005-02-11 | 2007-11-07 | Amylin Pharmaceuticals Inc | Polipeptidos del analogo e hibrido del peptido inhibidor gastrico con propiedades seleccionables. |
US7629315B2 (en) | 2005-03-09 | 2009-12-08 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compositions for blocking the inhibitory effect of human CRP on human leptin |
BRPI0614649A2 (pt) | 2005-08-11 | 2011-04-12 | Amylin Pharmaceuticals Inc | polipeptìdeos hìbridos com propriedades selecionáveis |
EP1922336B1 (en) | 2005-08-11 | 2012-11-21 | Amylin Pharmaceuticals, LLC | Hybrid polypeptides with selectable properties |
ES2319048B1 (es) * | 2007-06-20 | 2010-02-10 | Universitat De Les Illes Balears | Uso de leptina en el tratamiento de alteraciones en los habitos alimentarios. |
US8889622B2 (en) | 2007-07-25 | 2014-11-18 | Washington University | Methods of inhibiting seizure in a subject |
GB2451858A (en) * | 2007-08-15 | 2009-02-18 | Sergiy Konovchuk | Methods of reducing body fat and treating obesity |
MX2010006259A (es) | 2007-12-05 | 2010-08-23 | Astrazeneca Ab | Piperazinas como agentes antiobesidad. |
WO2009071668A2 (en) | 2007-12-05 | 2009-06-11 | Biovitrum Ab (Publ) | Piperazine derivatives and their use as leptin receptor modulators |
EP2313096A1 (en) * | 2008-06-04 | 2011-04-27 | AstraZeneca AB (Publ) | New compounds v |
RU2010148900A (ru) * | 2008-06-04 | 2012-07-20 | Астразенека Аб (Se) | Новые производные в качестве миметиков модуляторов лептинового рецептора |
EP2416797A4 (en) | 2009-04-10 | 2013-04-24 | Amylin Pharmaceuticals Llc | AMYLINAGONIST COMPOUNDS FOR OXYGEN ANIMAL MICE |
ES2602436T3 (es) * | 2010-05-11 | 2017-02-21 | The U.S.A. As Represented By The Secretary, Department Of Health And Human Services | Inhibidor basado en péptido de la activación de interleucina 10 o STAT-3 |
BR122021020041B1 (pt) | 2010-09-28 | 2023-03-07 | Amylin Pharmaceuticals, Llc | Polipeptídeo quimérico, seu uso e composição que o compreende |
CN104829707B (zh) * | 2015-05-06 | 2017-12-19 | 广东省生物资源应用研究所 | 一条cd环和e螺旋区突变的瘦素活性肽及其编码基因和应用 |
CN110183530A (zh) * | 2019-06-21 | 2019-08-30 | 深圳市亚辉龙生物科技股份有限公司 | 瘦素免疫原、杂交瘤细胞、单克隆抗体、多克隆抗体及应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
US5552523A (en) * | 1995-01-31 | 1996-09-03 | Eli Lilly And Company | Anti-obesity proteins |
AU4766596A (en) * | 1995-01-31 | 1996-08-21 | Eli Lilly And Company | Ob gene product antibodies |
AU4766096A (en) * | 1995-01-31 | 1996-08-21 | Eli Lilly And Company | Anti-obesity proteins |
WO1996031526A1 (en) * | 1995-04-06 | 1996-10-10 | Amylin Pharmaceuticals, Inc. | Anti-obesity agents |
GB9509164D0 (en) * | 1995-05-05 | 1995-06-28 | Smithkline Beecham Plc | Novel compounds |
-
1997
- 1997-06-04 TR TR1998/02534T patent/TR199802534T2/xx unknown
- 1997-06-04 NZ NZ332879A patent/NZ332879A/xx not_active IP Right Cessation
- 1997-06-04 EP EP97929156A patent/EP0912609A2/en not_active Withdrawn
- 1997-06-04 CN CN97195311A patent/CN1221426A/zh active Pending
- 1997-06-04 BR BR9709529A patent/BR9709529A/pt not_active Application Discontinuation
- 1997-06-04 AR ARP970102432A patent/AR008765A1/es unknown
- 1997-06-04 WO PCT/EP1997/002968 patent/WO1997046585A2/en not_active Application Discontinuation
- 1997-06-04 KR KR1019980709976A patent/KR20000016402A/ko not_active Application Discontinuation
- 1997-06-04 IL IL12715397A patent/IL127153A0/xx unknown
- 1997-06-04 AU AU33372/97A patent/AU3337297A/en not_active Abandoned
- 1997-06-04 CA CA002257240A patent/CA2257240A1/en not_active Abandoned
- 1997-06-04 PL PL97330361A patent/PL330361A1/xx unknown
- 1997-06-04 JP JP10500240A patent/JP2000512137A/ja active Pending
- 1997-06-04 CZ CZ983978A patent/CZ397898A3/cs unknown
-
1998
- 1998-12-04 NO NO985683A patent/NO985683L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR008765A1 (es) | 2000-02-23 |
WO1997046585A3 (en) | 1998-04-23 |
CN1221426A (zh) | 1999-06-30 |
EP0912609A2 (en) | 1999-05-06 |
PL330361A1 (en) | 1999-05-10 |
WO1997046585A2 (en) | 1997-12-11 |
JP2000512137A (ja) | 2000-09-19 |
NZ332879A (en) | 2000-09-29 |
TR199802534T2 (xx) | 1999-03-22 |
NO985683D0 (no) | 1998-12-04 |
IL127153A0 (en) | 1999-09-22 |
NO985683L (no) | 1998-12-04 |
BR9709529A (pt) | 1999-08-10 |
KR20000016402A (ko) | 2000-03-25 |
CA2257240A1 (en) | 1997-12-11 |
CZ397898A3 (cs) | 1999-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3337297A (en) | Fragments of leptin (ob protein) | |
AU5081298A (en) | Surgical method and composition therefor | |
AU688210B2 (en) | Recombinant obese (Ob) proteins | |
AU5721798A (en) | Human mage-like protein | |
AU4922497A (en) | Interleukin-18-receptor proteins | |
AU2517397A (en) | Document of value | |
AU4467497A (en) | Chaperone fragments | |
AU2548097A (en) | Formulations of ob protein | |
AU6721696A (en) | Cd44-like protein | |
AU5796298A (en) | Secreted human proteins | |
AU3902297A (en) | Two human nsp-like proteins | |
AU4480697A (en) | Human nm23-like protein | |
AU4750097A (en) | Human reg i-gamma protein | |
AU5427398A (en) | Cytoperfusion of tissue specimens | |
AU3451397A (en) | Modified protein g and fragments thereof | |
AU4824197A (en) | Novel human lim proteins | |
AU3020899A (en) | Compositions and methods for protein secretion | |
AU1538497A (en) | Anti-gp46 antibodies and fragments thereof and their use | |
AU1750997A (en) | Obesity protein formulations | |
AU2541397A (en) | Tissue remodeling proteins | |
AU7584696A (en) | Type ix collagen and fragments thereof | |
AU1705197A (en) | Obesity protein formulations | |
AU2111997A (en) | Assays using cross-linked polypeptide fragments of beta-galactosidase | |
AU2243997A (en) | Obesity protein formulations | |
AU1747297A (en) | Obesity protein formulations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK5 | Application lapsed section 142(2)(e) - patent request and compl. specification not accepted |